-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Allantoin in Epidermolysis Bullosa
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Allantoin in Epidermolysis Bullosa report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Allantoin in Epidermolysis Bullosa Drug Details: Allantoin (SD-101) is under development...
-
Product Insights
NewOlive Healthcare Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Olive Healthcare Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Olive Healthcare Inc. is a firm that is providing wellness and medical device services for quantitative body composition monitoring, which is an important aspect of the new prevention-based healthcare paradigm. The company is headquartered in Republic of Korea (South Korea). GlobalData's Medical Devices company profile report, “Olive Healthcare Inc Pipeline Insight and Competitive Landscape, 2023" provides information about the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pentosan Polysulfate Sodium in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pentosan Polysulfate Sodium in Osteoarthritis Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pentosan Polysulfate Sodium in Osteoarthritis Pain Drug Details: Pentosan...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pentosan Polysulfate Sodium in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pentosan Polysulfate Sodium in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pentosan Polysulfate Sodium in...
-
Sector Analysis
NewAttention Deficit Hyperactivity Disorder (ADHD) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Attention Deficit Hyperactivity Disorder (ADHD) market through 2032. The prevalent cases of ADHD in the 7MM will increase from 21,141,036 to 21,970,997, at an annual growth rate (AGR) of 0.4% over the forecast period. The ADHD market was valued at $11.9 billion in the 2022 baseline year. Over the 10-year forecast period, the market is projected to decline at a...
-
Product Insights
NewHernia Repair Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hernia Repair Devices Pipeline Market Report Overview Hernia Repair Device is a hernia mesh used to cure a hernia. Hernia is a condition where an organ or tissue bulges out through a weak spot in the surrounding muscle or connective tissue and can arise in a variety of locations throughout the body, including the pelvis, abdomen, and diaphragm. The hernia repair devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at...
-
Sector Analysis
NewAmyotrophic Lateral Sclerosis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2029
This report covers the 8MM (US, France, Germany, Italy, Spain, UK, Japan and Canada) and provides an Excel-based forecast model for the Amyotrophic Lateral Sclerosis (ALS) market through 2029. The prevalence of ALS is increasing at a steady rate, in line with population growth in the 8MM, at an annual growth rate (AGR) of 0.79%.The diagnosed prevalent cases of ALS across the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and Canada) are expected to increase from...
-
Sector Analysis
NewBronchiectasis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2033
Bronchiectasis Market Report Overview The Bronchiectasis market across the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and China) was valued at $1.4 billion in 2023 and the market will grow at a CAGR of more than 3% from 2023 to 2033. The 7MM (China, Japan, the United Kingdom, Spain, Italy, Germany, France, and the US). The market growth is attributed to the launch of brensocatib and an increase in the number of diagnosed prevalent cases of bronchiectasis. Bronchiectasis Market...
-
Sector Analysis
Ovarian Cancer Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
Ovarian Cancer Market Report Overview The ovarian cancer market across the 7MM was valued at $3.3 billion in 2022. The market will grow at a CAGR of more than 1% from 2022 to 2032. The 7MM includes the US, France, Germany, Italy, Spain, the UK, and Japan. Ovarian cancer is one of the most lethal gynecological cancers worldwide. Approximately 90% of ovarian cancer cases are epithelial, with distinct sites of origin arising from the ovarian surface epithelium or distal fallopian...